[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fi0RVjOoExRs5CnEnbIhRq5m0VyqxZCAwrtQiQWuej5o":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":36,"phaseBuckets":42,"rows":49},"Gazi University",[4],509,false,85,0,47159,3,501,[14,17,20,23,26,28,31,34],{"name":15,"count":16},"Multiple Sclerosis",24,{"name":18,"count":19},"Cerebral Palsy",14,{"name":21,"count":22},"Parkinson Disease",13,{"name":24,"count":25},"Healthy",9,{"name":27,"count":25},"Anxiety",{"name":29,"count":30},"Periodontitis",8,{"name":32,"count":33},"Gingival Recession",6,{"name":35,"count":33},"Stroke",[37],{"nctId":38,"briefTitle":39,"date":40,"intervention":41},"NCT07394062","Real-World Comparison of Chemo-Immunotherapy Regimens in Metastatic NSCLC With PD-L1 \u003C50% (ALCG-01)","2027-08","Pembrolizumab",[43,44,45,46,47,48],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[50,77,95,113,145,163,188,214,240,269,287,312,338],{"intervention":41,"totalTrials":51,"cells":52},1,{"EARLY_PHASE1":53,"PHASE1":55,"PHASE2":57,"PHASE3":59,"PHASE4":61,"NA":63},{"trials":54,"activeCount":9},[],{"trials":56,"activeCount":9},[],{"trials":58,"activeCount":9},[],{"trials":60,"activeCount":9},[],{"trials":62,"activeCount":9},[],{"trials":64,"activeCount":51,"soonestReadout":40},[65],{"nctId":38,"briefTitle":39,"status":66,"phases":67,"primaryCompletion":40,"completion":68,"start":69,"enrollment":70,"conditions":71,"interventions":74},"RECRUITING",[],"2028-02","2026-02-01",400,[72,73],"Nonsmall Cell Lung Cancer, Stage IV","Metastatic Nonsmall Cell Lung Cancer",[41,75,76],"Nivolumab","Ipilimumab",{"intervention":75,"totalTrials":51,"cells":78},{"EARLY_PHASE1":79,"PHASE1":81,"PHASE2":83,"PHASE3":85,"PHASE4":87,"NA":89},{"trials":80,"activeCount":9},[],{"trials":82,"activeCount":9},[],{"trials":84,"activeCount":9},[],{"trials":86,"activeCount":9},[],{"trials":88,"activeCount":9},[],{"trials":90,"activeCount":51,"soonestReadout":40},[91],{"nctId":38,"briefTitle":39,"status":66,"phases":92,"primaryCompletion":40,"completion":68,"start":69,"enrollment":70,"conditions":93,"interventions":94},[],[72,73],[41,75,76],{"intervention":76,"totalTrials":51,"cells":96},{"EARLY_PHASE1":97,"PHASE1":99,"PHASE2":101,"PHASE3":103,"PHASE4":105,"NA":107},{"trials":98,"activeCount":9},[],{"trials":100,"activeCount":9},[],{"trials":102,"activeCount":9},[],{"trials":104,"activeCount":9},[],{"trials":106,"activeCount":9},[],{"trials":108,"activeCount":51,"soonestReadout":40},[109],{"nctId":38,"briefTitle":39,"status":66,"phases":110,"primaryCompletion":40,"completion":68,"start":69,"enrollment":70,"conditions":111,"interventions":112},[],[72,73],[41,75,76],{"intervention":114,"totalTrials":51,"cells":115},"Levobupivacaine (as Levobupivacaine Hydrochloride) 75 Mg\u002F10 mL Solution for Injection Ampoule",{"EARLY_PHASE1":116,"PHASE1":118,"PHASE2":120,"PHASE3":122,"PHASE4":124,"NA":143},{"trials":117,"activeCount":9},[],{"trials":119,"activeCount":9},[],{"trials":121,"activeCount":9},[],{"trials":123,"activeCount":9},[],{"trials":125,"activeCount":9},[126],{"nctId":127,"briefTitle":128,"status":129,"phases":130,"primaryCompletion":131,"completion":132,"start":133,"enrollment":134,"conditions":135,"interventions":141},"NCT04245774","Comparing the Effects of Levobupivacaine and Bupivacaine in Saddle Spinal Anesthesia","COMPLETED",[47],"2008-08-13","2008-12-17","2007-11-21",60,[136,137,138,139,140],"Outpatients","General Surgery","Anorectal Disorder","Anesthesia","Drug Effect",[114,142],"Bupivacaine\u002FDextrose",{"trials":144,"activeCount":9},[],{"intervention":142,"totalTrials":51,"cells":146},{"EARLY_PHASE1":147,"PHASE1":149,"PHASE2":151,"PHASE3":153,"PHASE4":155,"NA":161},{"trials":148,"activeCount":9},[],{"trials":150,"activeCount":9},[],{"trials":152,"activeCount":9},[],{"trials":154,"activeCount":9},[],{"trials":156,"activeCount":9},[157],{"nctId":127,"briefTitle":128,"status":129,"phases":158,"primaryCompletion":131,"completion":132,"start":133,"enrollment":134,"conditions":159,"interventions":160},[47],[136,137,138,139,140],[114,142],{"trials":162,"activeCount":9},[],{"intervention":164,"totalTrials":51,"cells":165},"Hyaluronic acid group",{"EARLY_PHASE1":166,"PHASE1":168,"PHASE2":170,"PHASE3":182,"PHASE4":184,"NA":186},{"trials":167,"activeCount":9},[],{"trials":169,"activeCount":9},[],{"trials":171,"activeCount":9},[172],{"nctId":173,"briefTitle":174,"status":129,"phases":175,"primaryCompletion":176,"completion":177,"start":178,"enrollment":179,"conditions":180,"interventions":181},"NCT03871218","Effect of Hyaluronic-acid on the Healing After Free Gingival Graft",[45],"2018-04-01","2018-12-01","2017-04-01",40,[32],[164],{"trials":183,"activeCount":9},[],{"trials":185,"activeCount":9},[],{"trials":187,"activeCount":9},[],{"intervention":189,"totalTrials":51,"cells":190},"Flurbiprofen",{"EARLY_PHASE1":191,"PHASE1":204,"PHASE2":206,"PHASE3":208,"PHASE4":210,"NA":212},{"trials":192,"activeCount":9},[193],{"nctId":194,"briefTitle":195,"status":129,"phases":196,"primaryCompletion":197,"completion":198,"start":199,"enrollment":200,"conditions":201,"interventions":203},"NCT03165929","Oral Flurbiprofen Spray for Mucosal Graft Harvesting at the Palatal Area",[43],"2017-02","2017-03","2016-05",48,[202],"Surgery, Oral",[189],{"trials":205,"activeCount":9},[],{"trials":207,"activeCount":9},[],{"trials":209,"activeCount":9},[],{"trials":211,"activeCount":9},[],{"trials":213,"activeCount":9},[],{"intervention":215,"totalTrials":51,"cells":216},"Clobetasol Propionate 0.05% Cream",{"EARLY_PHASE1":217,"PHASE1":219,"PHASE2":221,"PHASE3":223,"PHASE4":225,"NA":227},{"trials":218,"activeCount":9},[],{"trials":220,"activeCount":9},[],{"trials":222,"activeCount":9},[],{"trials":224,"activeCount":9},[],{"trials":226,"activeCount":9},[],{"trials":228,"activeCount":9},[229],{"nctId":230,"briefTitle":231,"status":129,"phases":232,"primaryCompletion":233,"completion":234,"start":235,"enrollment":236,"conditions":237,"interventions":239},"NCT06856590","ZINCLO-HAND: Zinc and Clobetasol for the Prevention of Regorafenib-Induced Hand-Foot Skin Reaction",[48],"2025-09-01","2025-09-07","2025-02-20",150,[238],"Hand-Foot Skin Reaction (HFSR)",[215],{"intervention":241,"totalTrials":51,"cells":242},"Platelet-rich fibrin",{"EARLY_PHASE1":243,"PHASE1":245,"PHASE2":247,"PHASE3":249,"PHASE4":251,"NA":253},{"trials":244,"activeCount":9},[],{"trials":246,"activeCount":9},[],{"trials":248,"activeCount":9},[],{"trials":250,"activeCount":9},[],{"trials":252,"activeCount":9},[],{"trials":254,"activeCount":9},[255],{"nctId":256,"briefTitle":257,"status":129,"phases":258,"primaryCompletion":259,"completion":260,"start":261,"enrollment":262,"conditions":263,"interventions":267},"NCT07530068","Adjacent Molar Outcomes After Third Molar Surgery With PRF or Collagen Sponge",[48],"2025-11-30","2026-02-28","2025-02-28",29,[264,265,266],"Impacted Mandibular Third Molar","Wound Healing","Postoperative Pain",[241,268],"Absorbable Collagen Sponge",{"intervention":268,"totalTrials":51,"cells":270},{"EARLY_PHASE1":271,"PHASE1":273,"PHASE2":275,"PHASE3":277,"PHASE4":279,"NA":281},{"trials":272,"activeCount":9},[],{"trials":274,"activeCount":9},[],{"trials":276,"activeCount":9},[],{"trials":278,"activeCount":9},[],{"trials":280,"activeCount":9},[],{"trials":282,"activeCount":9},[283],{"nctId":256,"briefTitle":257,"status":129,"phases":284,"primaryCompletion":259,"completion":260,"start":261,"enrollment":262,"conditions":285,"interventions":286},[48],[264,265,266],[241,268],{"intervention":288,"totalTrials":51,"cells":289},"Hyaluronic acid",{"EARLY_PHASE1":290,"PHASE1":292,"PHASE2":294,"PHASE3":296,"PHASE4":298,"NA":300},{"trials":291,"activeCount":9},[],{"trials":293,"activeCount":9},[],{"trials":295,"activeCount":9},[],{"trials":297,"activeCount":9},[],{"trials":299,"activeCount":9},[],{"trials":301,"activeCount":9},[302],{"nctId":303,"briefTitle":304,"status":129,"phases":305,"primaryCompletion":306,"completion":307,"start":308,"enrollment":179,"conditions":309,"interventions":311},"NCT03920553","Hyaluronic Acid Application Following Frenectomy",[48],"2019-03-15","2019-04-11","2019-01-02",[310],"Frenulum; Hypertrophy, Lip",[288],{"intervention":313,"totalTrials":51,"cells":314},"Remifentanil",{"EARLY_PHASE1":315,"PHASE1":317,"PHASE2":319,"PHASE3":321,"PHASE4":323,"NA":325},{"trials":316,"activeCount":9},[],{"trials":318,"activeCount":9},[],{"trials":320,"activeCount":9},[],{"trials":322,"activeCount":9},[],{"trials":324,"activeCount":9},[],{"trials":326,"activeCount":9},[327],{"nctId":328,"briefTitle":329,"status":129,"phases":330,"primaryCompletion":331,"completion":332,"start":333,"enrollment":179,"conditions":334,"interventions":336},"NCT01491009","Comparison of Remifentanil With Dexmedetomidine or Midazolam in Regards of Sedation Effectivity and Postoperative Cognitive Functions in Cystoscopies",[48],"2007-02","2010-11","2006-05",[335],"Postoperative Cognitive Functions",[313,337],"Midazolam",{"intervention":337,"totalTrials":51,"cells":339},{"EARLY_PHASE1":340,"PHASE1":342,"PHASE2":344,"PHASE3":346,"PHASE4":348,"NA":350},{"trials":341,"activeCount":9},[],{"trials":343,"activeCount":9},[],{"trials":345,"activeCount":9},[],{"trials":347,"activeCount":9},[],{"trials":349,"activeCount":9},[],{"trials":351,"activeCount":9},[352],{"nctId":328,"briefTitle":329,"status":129,"phases":353,"primaryCompletion":331,"completion":332,"start":333,"enrollment":179,"conditions":354,"interventions":355},[48],[335],[313,337]]